Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372475 · ClinicalTrials.gov registry record · Phase 3
Hymovis™ Versus Placebo in Knee Osteoarthritis
A Phase 3 study, sponsored by Fidia Farmaceutici s.p.a..
- Completed
- Registry status
- Phase 3
- Development phase
- 800
- Enrollment target
NCT01372475 is a Phase 3 study that has completed, run by Fidia Farmaceutici s.p.a.. The registered enrollment target is 800 participants.
The verdict
NCT01372475, a Phase 3 study, has completed, sponsored by Fidia Farmaceutici s.p.a..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 800 participants
- Enrollment target
Study Summary
Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.
Interventions
- DEVICE Hymovis Intra-articular Injection
- PROCEDURE Phosphate Buffered Saline Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01372475
The ClinicalTrials.gov registry entry for NCT01372475 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fidia Farmaceutici s.p.a., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hymovis Intra-articular Injection is the first listed.
NCT01372475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01372475 about?
NCT01372475 is a clinical study titled "Hymovis™ Versus Placebo in Knee Osteoarthritis". Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.
What is the current status of trial NCT01372475?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 800 participants. The study started on 2011-03. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01372475?
The interventions under investigation include: Hymovis Intra-articular Injection (DEVICE), Phosphate Buffered Saline Injection (PROCEDURE).
Who is sponsoring clinical trial NCT01372475?
This trial is sponsored by Fidia Farmaceutici s.p.a., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.